RSNA 2013 

Abstract Archives of the RSNA, 2013


SSC03-01

Role of 4D Flow MRI in Detecting Hemodynamic Changes in Patients with Pulmonary Arterial Hypertension

Scientific Formal (Paper) Presentations

Presented on December 2, 2013
Presented as part of SSC03: Cardiac (Quantitative Imaging)

Participants

Pegah Entezari MD, Presenter: Nothing to Disclose
Susanne Schnell, Abstract Co-Author: Nothing to Disclose
Naomi C. Chesler PhD, Abstract Co-Author: Nothing to Disclose
Christopher Jean-Pierre Francois MD, Abstract Co-Author: Nothing to Disclose
Alejandro Roldan PhD, Abstract Co-Author: Nothing to Disclose
Oliver Wieben PhD, Abstract Co-Author: Nothing to Disclose
Jeremy Douglas Collins MD, Abstract Co-Author: Consultant, C. R. Bard, Inc
James Christopher Carr MD, Abstract Co-Author: Speaker, Lantheus Medical Imaging, Inc
Alex Barker, Abstract Co-Author: Nothing to Disclose
Michael Markl PhD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To evaluate peak velocity, net flow, vessel diameter and wall shear stress (WSS) in the proximal pulmonary arteries of normotensive controls and patients with pulmonary arterial hypertension (PAH) using 4D flow MRI.

METHOD AND MATERIALS

With IRB approval, 10 patients (age: 57±10, 5 females) and 9 volunteers (age: 40 ±12, 6 females) were scanned on a 3T MR system. Time-resolved 3D pulmonary flow was measured using 4DMRI with full coverage of the right ventricular outflow tract, pulmonary trunk (PT) and right and left pulmonary branches (RPA and LPA). Net flow and maximum velocity were quantified at the level of PT, RPA and LPA. WSS and vessel diameter were also measured in analysis planes positioned at these three levels in both groups.

RESULTS

Net flow in PAH patients (PT: 52.7±11, LPA: 21.5±5, RPA: 26.2±7 ml/cycle) was significantly lower compared to controls (PT: 68.3±13, LPA: 29.3±7, RPA: 32.7±5 ml/cycle, p-value< 0.05). The same pattern was observed for peak velocity in PAH patients (PT: 0.5±0.1, LPA: 0.3±0.1, RPA: 0.4±0.1 m/s) compared to the controls (PT: 0.8±0.1, LPA: 0.7±0.2, RPA: 0.9±0.2 m/s, p-value< 0.05). In addition, PAH arteries had a significantly larger diameter (PT: 3.4±0.5, LPA: 2.3±0.3, RPA: 2.4±0.3 cm) compared to the normal population (PT: 2.6±0.2, LPA: 1.8±0.2, RPA: 1.7±0.3 cm, p-value< 0.001). As shown in Figure 1, PAH patients had reduced WSS at all three measurement positions, compared to volunteers.

CONCLUSION

4D flow MRI illustrates distinct hemodynamic changes in PAH patients compared to a normal population. The significant reduction in net flow, peak velocity and an increase in PA lumen diameter in patients resulted in decreased WSS values, as compared to normal volunteers.

CLINICAL RELEVANCE/APPLICATION

Pulmonary hypertension is associated with right heart failure, but its effect on arterial diameter and hemodynamic factors (i.e. velocity, flow, WSS) and their role in disease progression is not clear

Cite This Abstract

Entezari, P, Schnell, S, Chesler, N, Francois, C, Roldan, A, Wieben, O, Collins, J, Carr, J, Barker, A, Markl, M, Role of 4D Flow MRI in Detecting Hemodynamic Changes in Patients with Pulmonary Arterial Hypertension.  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13016229.html